Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2022-02-08 08:00Moberg Pharmas Year-end report 2021Read more 2022-02-01 08:00The Nomination Committee's proposal to the Annual General Meeting 2022Read more 2021-12-23 08:00The Medical Products Agency in Sweden will be reference member state for Moberg Pharma's European registration applicationRead more 2021-12-06 08:00Moberg Pharma's Chairman Peter Wolpert becomes CEO of Industrifonden and is therefore not available for re-electionRead more 2021-11-09 08:00Interim report January - September 2021Read more 2021-11-08 08:00Moberg Pharma enters into collaboration with Allderma for launch in ScandinaviaRead more Pagination First page Previous page … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Last page Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2020-11-27 08:00Moberg Pharma announces the final terms of the fully guaranteed rights issueRead more 2020-11-16 15:00OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listingRead more 2020-11-10 08:00Extended fiscal year July 2019 - December 2020 Interim report July - September 2020Read more 2020-11-06 08:02Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 millionRead more 2020-11-06 08:01Moberg Pharma intends to distribute and separately list BupiZenge[®] (BUPI)Read more 2020-11-06 08:00Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)Read more Pagination First page Previous page … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Last page
